Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27943675
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 ACS+Nano
2017 ; 11
(1
): 314-324
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Mechanism of Shiga Toxin Clustering on Membranes
#MMPMID27943675
Pezeshkian W
; Gao H
; Arumugam S
; Becken U
; Bassereau P
; Florent JC
; Ipsen JH
; Johannes L
; Shillcock JC
ACS Nano
2017[Jan]; 11
(1
): 314-324
PMID27943675
show ga
The bacterial Shiga toxin interacts with its cellular receptor, the
glycosphingolipid globotriaosylceramide (Gb3 or CD77), as a first step to
entering target cells. Previous studies have shown that toxin molecules cluster
on the plasma membrane, despite the apparent lack of direct interactions between
them. The precise mechanism by which this clustering occurs remains poorly
defined. Here, we used vesicle and cell systems and computer simulations to show
that line tension due to curvature, height, or compositional mismatch, and lipid
or solvent depletion cannot drive the clustering of Shiga toxin molecules. By
contrast, in coarse-grained computer simulations, a correlation was found between
clustering and toxin nanoparticle-driven suppression of membrane fluctuations,
and experimentally we observed that clustering required the toxin molecules to be
tightly bound to the membrane surface. The most likely interpretation of these
findings is that a membrane fluctuation-induced force generates an effective
attraction between toxin molecules. Such force would be of similar strength to
the electrostatic force at separations around 1 nm, remain strong at distances up
to the size of toxin molecules (several nanometers), and persist even beyond.
This force is predicted to operate between manufactured nanoparticles providing
they are sufficiently rigid and tightly bound to the plasma membrane, thereby
suggesting a route for the targeting of nanoparticles to cells for biomedical
applications.